Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

CPR Exam 1 > DSA 1 > Flashcards

DSA 1 Flashcards

1
Q

What is pharmacodynamics?

A

How the drug affects the body MOA, type of receptor it binds to, and dose-response curves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is pharmacokinetics

A

How the body affects the drug; ADME (absorption, distribution, metabolism and elimination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Receptor + drug => activates receptor => initiates biochemical effects => cause drug effects Receptors have a _______ role.

A

regulatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inert binding site is?

A

where a drug binds, however it does not change fx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ligand is a?

A

hormone or a drug that binds to a receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If a drug-receptor bind covalently, the interaction is ______.

A

Irreversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If a drug-receptor binds non-covalently, the interaction is ________.

A

Reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If a drug-receptor bind covalently, removal of the drug or re-activation of the receptor requires what?

A

REmake a receptor or remove the drug using an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most drugs bind to receptors ______

A

NON-covalently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List non-covalent interactions from strongest => weakest.

A
  • Ionic: [position ion] + [negative ion] - Hydrogen bonds: - Hydrophobic interactions: hydrophobic regions of drug + receptor interact.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What 3 factors describe how well a drug and receptor interact?

A
  1. Affinity 2. Selectivity 3. Intrinsic activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is affinity?

A

how well a drug binds to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

High affinity: _____ interaction and ____ drug is needed to create a response.

A

good LESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Low affinity: ____ interaction and ___ drug is needed to make a response.

A

BAD MORE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is KD?

A

KD (Equilibrium dissociation constant) is the concentration of the drug where 50% of the receptors are occupied.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the relationship between affinity and KD?

A

High affinity = lower KD Lower affinity= higher KD because we need more the drug to occupy 50% of the receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Selectivity of a drug is? What determines a drugs selectivity

A

Selectivity is the degree to which a drug acts on a given site relative to other site (within a range) It is determined by the drugs affinity at different binding sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a intrinsic activity?

A

The ability for the drug to produce a physiological response when it binds to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which have intrinsic activity; agonist or ANT?

A

Agonists: not ANT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What happens when a AGO binds to receptor

A

=> stabilizes it in active confirmation => cause a physiological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ANT do not have physiological response. What do they do then?

A

They do not change the function but they bind => if ago is present, prevent the activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what do ANT do when an AGO is NOT present?

A

no effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Full AGO: _____ activate receptors, produce a ______ effect when bound to all receptors and have _____ intrinsic activity.

A

Fully; max; max

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Partial AGO ______ activate receptors, produce a ______ effect when bound to all receptors and intrinsic efficacy _________.

A

partially sub-max IA will depend on the drug but it is always sub-max

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
A partial AGO will have _____ affinity for both Ri and Ra forms
intermediate
26
What do inverse AGO do?
Has the opposite effect of a full/partial AGO; decrease receptor signaling, decrease response, its IA will inhibit the function of the receptor
27
ANT has _____ affinity for both Ri (inactive receptor that produces no effect) and Ra (active receptor that can activate downstream mechanisms that produces a small observable effect, even in the absence of ligands) and have ____ level of constitutive activity.
equal; same
28
\_\_\_\_\_\_\_\_\_\_\_ is have action at the same reeptor as endogenous ligands or AGO drugs ______ occurs when a chemical ANT prevents drug from binding
Pharmacologic ANT Chemical ANT
29
Inverse AGO have a higher affinity for the ____ form
Ri
30
What are the types of pharmacologic ANT?
1. Competitive ANT 2. Non-competitive ANT; includes both irreversible ANT and allosteric ANT.
31
\_\_\_\_\_\_\_\_\_ irreversibly (covalently) and block where AGO bind.
Irreversible ANT
32
\_\_\_\_\_\_\_\_ bind to ANOTHER site than the AGO site to prevent or reduce the AGO from binding or activation of the receptor.
Allosteric ANT
33
Competitive ANT: higher concentrations of the AGO are required to displace the ANT and cause an effect (shifts to the \_\_\_\_)
right
34
EC50 is what?
concentration of a drug that gives HALF of the max response.
35
What is Vmax
max rate of reaction when all receptors are bound
36
Competitive ANT: EC50 \_\_\_\_; Vmax \_\_\_\_
EC50 increases Vmax: does not change
37
Noncompetitive ANT: EC50 \_\_\_\_\_; Vmax \_\_\_\_
EC50 does not change Vmax: decreases
38
The dose-response curve makes a _______ when plotted arithmetically.
hyperbolic curve
39
1. The dose-response curve makes a ________ curve when it is plotted using a logarithm: most common!!!!
**Sigmoidal**
40
1. **Describe the dose-response curve parameters, such as _ED50_ and _Emax._**
**Emax**: max effect that a drug can make **ED50 (effective dose)**: dose of the drug that makes 50% of the max effect
41
**Distinguish between quantal and graded responses and recognize when a response is graded vs. quantal.**
* **Graded response (how much)** of a drug will produce a certain response; it is usually a mean in a population and the magnitude will vary. * **Quantal response (all or none/binary)** asks if a response will occur and requires a pre-defined response and is used to describ e a frequency of a response in a large population
42
A ____ response is seen an a individual/mean value in a population and increases with dose.
**Graded response**
43
\_\_\_\_\_\_\_ response is seen in a population and is either [present/absent] in a single person.
**Quantal response**
44
What 2 questions do **quantal responses** answer?
* **1. In how many** (in how many people will death occur) * **2. Does the response occur or not** (yes or no)
45
What questions do **graded responses** answer?
**How much** Usually a mean value in a population or a single person
46
Non-cumulative quantal dose-response curve: shows us what?
**the # of ppl that response AT a dose and ONLY at that dose** 1. 20% of people in the population who take 10 mg of a drug will die
47
**Cumulative quantal dose-response curve** shows us what?
of people that response at a dose and at ALL doses lower than those dose. 1. 20% of people in population who take up 10 mg of a drug will die.
48
**Median effective dose (ED50)** is?
the **dose where 50% of the population react to the drug**
49
TD50
median toxic dose
50
LD50
**median lethal dose**
51
**TI**
Therapetuic index (TI) calculates the safety of a drug Higher TI=safer **TI= TD50/ED50**
52
**therapeutic window**
**Range of doses of a drug or its concentration in the body** that are safe and effective
53
**Potency**
the **dose of drug** needed to create a specific pharmacological effect
54
More **potent** drugs have _____ **ED50**
**lower**
55
More potent drugs will have a _____ **affinity** and a _____ **KD**
**higher** **lower**
56
On a sigmoidal DR curve, **potency** increases as EC50 \_\_\_\_ Potency increases going from \_\_\_\_\_
**decreases** **R =\> L**
57
**Efficacy** is?
can be measured by Emax; it is the max effect a drug can produce.
58
Efficacy is related to? What is it used to determine?
Total number of receptors that are available for drug to bind to. Determine the magnitude of clinical effect
59
High ____ =\> more effective
**High Emax**
60
On a DR, efficacy increases as a curve \_\_\_\_\_
goes up
61
**What do drugs target? (6)**
**1. Membrane receptors** **2. Cytoplasmic receptors** **3. Nuclear receptors** **4. Ion channels,** **5. Transport proteins** **6. enzymes**
62
**Kinases** do what?
covalently phosphorylate a protein using a phosphate lost from ATP =\> ADP
63
**Transcription factors (TFs)** bind to DNA using its _________ (defining feature) at the \_\_\_\_\_\_\_\_\_\_\_\_\_\_, located near coding sequence of gene, and control transcription from DNA =\> RNA
* **DNA-binding domain** * **Response element (enhancer or promotor region)**
64
TF MOA?
Promote the recruiment of RNA polymerase to genes via **activators** Inhibit the recruitment of RNA polyermase to genes via **inhibitors**
65
**1/3 of drugs act on GCPR**, which are **heterotrimeric** (alpha, beta and y subunits) What is the G-protein cycle?
1. AGO binds and activates the GCPR 2. Promotes release of GDP from alpha protein 3. GTP then binds to nucleotide binding site 4. Alpha-protein + GTP =\> causes G-protein to bind to the effector enzyme or ion channel. 5. Hydrolysis of GTP -\> GDP =\> signal terminated.
66
which G-protein: ## Footnote + AC and Src tyrosine kinases
Gs
67
What does Gi Gprotein do?
* **Inhibit AC 13, 5 and 6** * **Activate tyrosine kinase Src**
68
What does Gq do?
**+ PLC CB**
69
**_G 12/13_ does what?**
**+ Rho GTPases =\> Cytoskeletal rearrangements**
70
Describe the process of **densitization**.
* AGO binds to cell =\> cAMP * Continued prescence will reduce cAMP ersponse after a few minutes. * If AGO is removed after a short time, cells revoer FULL responsiveness to an additional AGO "resensitization". * Resensization does NOT occur if the cells are exposed to AGO repeatedly or for a long time
71
**What is the process of resensitization?**
* 1. AGO binds to a receptor =\> initiates signaling by promoting the receptor interaction with G protein * 2. GRK (G-protein-coupled receptor kinase) phosphorylates [AGO + receptor], preventing the Gs protein from binding to the receptor and promoting B-arrestin to bind. * 3. Receptor-arrestin complex bind to coated pits, which internalizes the receptor. * 4. AGO dissociated from internalized receptor =\> reduces B-Arr binding affinity, allowing phosphotase to dephosphorylate the receptor * 5. Receptor returns to plasma membrane
72
What promotes the **DOWN-regulation** of a receptor, instead of densitization?
Following the processes that occured before, if the AGO does not dissociate from the internalized receptor =\> B-arrestin will stay bound =\> **receptor is broken down by lysosomes.**
73
**27. Describe signaling involving cyclic AMP system and the role phosphodiesterase in regulating the intracellular concentration of this signaling intermediate.**
1. AGO binds to GCPR 2. +Gs 3. +AC (converts ATP =\> cAMP 4. cAMP activates PKA ## Footnote **PDE hydrolyzes cAMP to 5'AMP**
74
**Gq: Gq =\> PLC =\> PIP2 will split into IP3 and DAG** IP3 causes Ca2+ to be released from \_\_\_\_ What does DAG do?
SR + PKC
75
What receptors trasmit the action of growth factors?
**RTKs (receptor tyrosine kinases)**
76
Describe receptor tyrosine kinase signaling,
1. RTK is a transmembrane receptor: GFs bind (IGF, **insulin**, VEGF, EFG, NGF and PDGF), 2. Receptor converts from **inactive monomeric state =\> active dimeric state, where 2 receptor polypeptides bind non-covalently.** **3. Cytoplasmic domain is phosphorylated on tyrosine resides** **4. Activate and phosphorylates substrates (ATP-ADP)**
77
Receptors coupled to JAK kinases are coupled to JAKs, ______ tyrosine kinases.
**_cytosolic tryrosine kinases_**
78
receptors coupled to JAKs trasmit the effects of what?
**1. Growth hormones (somatotropin)** **2. Erythropoeitin** **3. Leptin** **4. Interferons** **5. IL 2-10 and 15**
79
ONce JAK kinases are activated, what do they do?
* Phosphorylate signal transducers and activate transcription (STAT) molecules * STAT dimers =\> go to nucleus =\> regulate transcription
80
Nuclear receptors are ______ TF that do what? What binds to them?
Ligand-activated modulate gene expression -lipophillic molecules (steroids, thyroid, vitD/A, lipid mediateors)
81
Name nuclear receptors
**1. androgen receptor** **2. estrogen receptor** **3. progesterone receptor** **4. Glucocorticoid receptors** **5. Mineralcorticoid receptors**
82
When do hormones that bind to nuclear receptors cause effects? How long do they last?
Produce effects after a LAG period of several hours or days ## Footnote **Effects can persist even afer concentration of AGO is 0**
83
Drug A is a partial AGO. Drug B is a full AGO. Thus, drug A has a _____ Emax than drug B.
**lower**
84
In the absence of other drugs, pindolol causes increase in HR by activating B-AR. When highly effective B-AR stimulants are present, pindolol causes a decrease in HR. Thus, it should be classified as a \_\_\_\_\_\_\_
**Partial AGO**
85
Competitive ANT: Agonist EC50 \_\_\_\_; Emax \_\_\_\_\_ Noncompetitive ANT: EC50 ______ but AGO Emax \_\_\_\_\_\_.
Competitive ANT: Agonist EC50 **increases**; Emax **does not change** Noncompetitive ANT: EC50 **does not change** but AGO Emax **decreases**.
86

CPR Exam 1 (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions